Xianjiang Lan

734 total citations
19 papers, 506 citations indexed

About

Xianjiang Lan is a scholar working on Molecular Biology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Xianjiang Lan has authored 19 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Genetics and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Xianjiang Lan's work include Hemoglobinopathies and Related Disorders (12 papers), RNA modifications and cancer (7 papers) and Epigenetics and DNA Methylation (7 papers). Xianjiang Lan is often cited by papers focused on Hemoglobinopathies and Related Disorders (12 papers), RNA modifications and cancer (7 papers) and Epigenetics and DNA Methylation (7 papers). Xianjiang Lan collaborates with scholars based in United States, China and Australia. Xianjiang Lan's co-authors include Gerd A. Blobel, Cheryl A. Keller, Ross C. Hardison, Junwei Shi, Belinda Giardine, Osheiza Abdulmalik, Sharon Dent, Jeremy D. Grevet, Michael P. Washburn and Boyko S. Atanassov and has published in prestigious journals such as Science, Nucleic Acids Research and Nature Genetics.

In The Last Decade

Xianjiang Lan

18 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xianjiang Lan United States 11 409 182 78 61 60 19 506
Ivan Krivega United States 11 793 1.9× 157 0.9× 80 1.0× 110 1.8× 56 0.9× 21 887
Katarzyna E. Kolodziej Netherlands 7 330 0.8× 119 0.7× 85 1.1× 55 0.9× 26 0.4× 7 432
Scott C. Crable United States 12 446 1.1× 124 0.7× 99 1.3× 111 1.8× 25 0.4× 15 572
Trisha A. Macrae United States 6 435 1.1× 41 0.2× 94 1.2× 52 0.9× 15 0.3× 8 537
Tony Brooks United Kingdom 9 272 0.7× 54 0.3× 57 0.7× 59 1.0× 11 0.2× 15 386
Mira Kassouf United Kingdom 8 453 1.1× 58 0.3× 89 1.1× 46 0.8× 8 0.1× 14 542
Zandra A. Jenkins New Zealand 10 349 0.9× 49 0.3× 38 0.5× 57 0.9× 10 0.2× 14 467
Ji Yoo Kim Japan 9 321 0.8× 29 0.2× 74 0.9× 62 1.0× 21 0.3× 13 446
Jon Kerry United Kingdom 8 405 1.0× 38 0.2× 103 1.3× 35 0.6× 9 0.1× 9 471
Tiziana Girardi Belgium 8 299 0.7× 38 0.2× 159 2.0× 36 0.6× 38 0.6× 10 533

Countries citing papers authored by Xianjiang Lan

Since Specialization
Citations

This map shows the geographic impact of Xianjiang Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianjiang Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianjiang Lan more than expected).

Fields of papers citing papers by Xianjiang Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianjiang Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianjiang Lan. The network helps show where Xianjiang Lan may publish in the future.

Co-authorship network of co-authors of Xianjiang Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Xianjiang Lan. A scholar is included among the top collaborators of Xianjiang Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianjiang Lan. Xianjiang Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ren, Ren, Han Zhao, Bin Xu, et al.. (2025). SWI/SNF complex-mediated ZNF410 cooperative binding maintains chromatin accessibility and enhancer activity. Cell Reports. 44(4). 115476–115476.
2.
Kaur, Gundeep, Ren Ren, Michal Hammel, et al.. (2023). Allosteric autoregulation of DNA binding via a DNA-mimicking protein domain: a biophysical study of ZNF410–DNA interaction using small angle X-ray scattering. Nucleic Acids Research. 51(4). 1674–1686. 8 indexed citations
3.
Qin, Kunhua, Xianjiang Lan, Peng Huang, et al.. (2023). Molecular basis of polycomb group protein-mediated fetal hemoglobin repression. Blood. 141(22). 2756–2770. 7 indexed citations
4.
Huang, Peng, Scott A. Peslak, Ren Ren, et al.. (2022). HIC2 controls developmental hemoglobin switching by repressing BCL11A transcription. Nature Genetics. 54(9). 1417–1426. 31 indexed citations
5.
Qin, Kunhua, Peng Huang, Ruopeng Feng, et al.. (2022). Dual function NFI factors control fetal hemoglobin silencing in adult erythroid cells. Nature Genetics. 54(6). 874–884. 25 indexed citations
6.
Huang, Peng, Scott A. Peslak, Eugene Khandros, et al.. (2021). HIC2 Controls Developmental Hemoglobin Switching By Repressing BCL11A Transcription. Blood. 138(Supplement 1). 571–571. 1 indexed citations
7.
Lan, Xianjiang, Ren Ren, Ruopeng Feng, et al.. (2020). ZNF410 Uniquely Activates the NuRD Component CHD4 to Silence Fetal Hemoglobin Expression. Blood. 136(Supplement 1). 54–54. 2 indexed citations
8.
Lan, Xianjiang, Ren Ren, Ruopeng Feng, et al.. (2020). ZNF410 Uniquely Activates the NuRD Component CHD4 to Silence Fetal Hemoglobin Expression. Molecular Cell. 81(2). 239–254.e8. 60 indexed citations
9.
Peslak, Scott A., Eugene Khandros, Peng Huang, et al.. (2020). HRI depletion cooperates with pharmacologic inducers to elevate fetal hemoglobin and reduce sickle cell formation. Blood Advances. 4(18). 4560–4572. 11 indexed citations
10.
Huang, Peng, Scott A. Peslak, Xianjiang Lan, et al.. (2020). The HRI-regulated transcription factor ATF4 activates BCL11A transcription to silence fetal hemoglobin expression. Blood. 135(24). 2121–2132. 43 indexed citations
11.
Wakabayashi, Aoi, Jeremy D. Grevet, Xianjiang Lan, et al.. (2019). Interrogating RNA Binding Proteins as Novel Regulators of Fetal Hemoglobin Expression. Blood. 134(Supplement_1). 966–966. 1 indexed citations
12.
Lan, Xianjiang, Eugene Khandros, Peng Huang, et al.. (2019). The E3 ligase adaptor molecule SPOP regulates fetal hemoglobin levels in adult erythroid cells. Blood Advances. 3(10). 1586–1597. 24 indexed citations
13.
Grevet, Jeremy D., Xianjiang Lan, Nicole Hamagami, et al.. (2018). Domain-focused CRISPR screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells. Science. 361(6399). 285–290. 106 indexed citations
14.
Lan, Xianjiang, Eugene Khandros, Jeremy D. Grevet, et al.. (2018). Domain-Focused CRISPR-Cas9 Screen Identifies the E3 Ubiquitin Ligase Substrate Adaptor Protein SPOP as a Novel Repressor of Fetal Hemoglobin. Blood. 132(Supplement 1). 414–414. 1 indexed citations
15.
Li, Wenqian, Boyko S. Atanassov, Xianjiang Lan, et al.. (2016). Cytoplasmic ATXN7L3B Interferes with Nuclear Functions of the SAGA Deubiquitinase Module. Molecular and Cellular Biology. 36(22). 2855–2866. 13 indexed citations
16.
Atanassov, Boyko S., Ryan D. Mohan, Xianjiang Lan, et al.. (2016). ATXN7L3 and ENY2 Coordinate Activity of Multiple H2B Deubiquitinases Important for Cellular Proliferation and Tumor Growth. Molecular Cell. 62(4). 558–571. 96 indexed citations
17.
Lan, Xianjiang, Boyko S. Atanassov, Wenqian Li, et al.. (2016). USP44 Is an Integral Component of N-CoR that Contributes to Gene Repression by Deubiquitinating Histone H2B. Cell Reports. 17(9). 2382–2393. 40 indexed citations
18.
Lan, Xianjiang, Evangelia Koutelou, Andreas Schibler, et al.. (2015). Poly(Q) Expansions in ATXN7 Affect Solubility but Not Activity of the SAGA Deubiquitinating Module. Molecular and Cellular Biology. 35(10). 1777–1787. 28 indexed citations
19.
Lan, Xianjiang, Lu Wen, Kui Li, et al.. (2011). Comparative analysis of duplicated sox21 genes in zebrafish. Development Growth & Differentiation. 53(3). 347–356. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026